Source comparison
Tesamorelin Vial Size: Dosing Format Comparison
Tesamorelin vial size affects more than just reconstitution math. It determines protocol flexibility, waste management, and cost per dose. Below is a comparison of the three most common vial formats used in research settings. 1mg per vial 1mL bacteriostatic wa
This comparison does not assign a generated winner or score.
- Tesamorelin vial size affects more than just reconstitution math. It determines protocol flexibility, waste management, and cost per dose. Below is a comparison of the three most common vial formats used in research settings.
- 1mg per vial
- 1mL bacteriostatic water
- 1mg/mL
- 1 dose
- 28 days
- Single-dose pilot studies, dosing trials where concentration must remain constant across subjects
- Minimal waste but requires frequent reconstitution. Suitable for short protocols only
- 2mg per vial
- 2mL bacteriostatic water
- 2 doses
- Standard multi-dose protocols, weekly dosing regimens, studies comparing 0.5mg vs 1mg doses
- Most common format. Balances multi-dose convenience with manageable injection volumes
- 5mg per vial
- 2.5mL bacteriostatic water
- 2mg/mL
- 5 doses (at 1mg each)
- Extended protocols, studies requiring consistent batch sourcing, high-volume labs
- Reduces per-dose cost and reconstitution frequency. Requires precise syringe measurement
- The 2mg tesamorelin vial size offers the best balance between dosing flexibility and waste minimization for most research applications. A single reconstitution event supports two to four administrations (depending on dose), fits within the 28-day refrigerated stability window, and allows straightforward 1mg/mL concentration that simplifies syringe measurement. Researchers working with 1mg vials face more frequent reconstitution steps, while those using 5mg vials must ensure their protocol will consume all five doses within four weeks or accept higher waste rates.